MS: Activity Drops May Predict Disability Worsening | Neurology Study

For individuals living with multiple sclerosis (MS), subtle shifts in daily activity levels may serve as an early warning sign of worsening disability. A new study published in Neurology on March 4, 2026, reveals that reductions in daytime activity patterns can precede clinical disability worsening in people with MS (PwMS). This finding underscores the potential of using objective activity monitoring to track disease progression and potentially intervene earlier.

Understanding the Connection: Activity and MS Progression

Multiple sclerosis is a chronic, often disabling disease that affects the central nervous system – the brain and spinal cord. Symptoms vary widely, but can include fatigue, difficulty walking, muscle weakness, and cognitive changes. Traditionally, assessing MS progression relies on clinical evaluations, which can be subjective and may not capture subtle changes over time. This new research suggests that changes in a person’s typical daily routine, as measured by accelerometers, could provide a more sensitive and objective indicator of disease activity.

The study focused on within-person changes, meaning researchers looked at how an individual’s own activity levels changed over time, rather than comparing activity levels between different people. This approach helps to account for the wide range of baseline activity levels among PwMS. Researchers found that decreases in daytime activity preceded documented worsening of clinical disability. This suggests that monitoring these activity patterns could potentially allow clinicians to identify individuals at risk of progression before it becomes apparent through traditional clinical assessments.

How Was the Study Conducted?

The research, detailed in the March 4th publication, utilized accelerometry – the use of motion sensors – to track activity levels in people with multiple sclerosis. Although the specific details of the study population and methodology aren’t fully detailed in the initial report, the findings highlight the potential of this technology. The study builds on a growing body of research exploring the use of wearable sensors and digital biomarkers in neurological conditions. The full study, published in Neurology, provides a deeper dive into the methodology and results.

What Does This Indicate for People with MS?

It’s important to emphasize that this study does not mean a drop in activity causes disability worsening. It suggests a correlation – a relationship between the two – but doesn’t prove causation. Other factors could be at play, and further research is needed to understand the underlying mechanisms. Still, the findings offer a potentially valuable tool for monitoring disease progression.

Currently, there is no recommendation for people with MS to actively monitor their activity levels based solely on this study. However, maintaining physical activity is generally recommended for people with MS, and this research reinforces the importance of paying attention to changes in one’s ability to engage in daily activities. The National Multiple Sclerosis Society provides comprehensive guidance on exercise and lifestyle physical activity recommendations for people with MS across different stages of the disease.

The Role of Activity Monitoring and Future Research

The study’s findings align with growing interest in using objective measures, like accelerometry, to track neurological conditions. Traditional methods of assessing disability in MS often rely on patient-reported outcomes and clinical examinations, which can be subjective and prone to variability. Objective measures offer the potential for more precise and sensitive monitoring of disease progression.

Researchers are also investigating how changes in activity patterns relate to brain atrophy – the loss of brain tissue – in people with MS. Medical Xpress reports on research exploring this connection, suggesting that activity patterns may reflect underlying neurological changes. This line of inquiry could lead to a better understanding of the biological mechanisms driving MS progression.

Limitations and Considerations

It’s crucial to acknowledge the limitations of this research. The study’s findings are based on a specific population and may not be generalizable to all people with MS. The study doesn’t address the reasons why activity levels decrease. Fatigue, pain, or other MS symptoms could all contribute to reduced activity, and it’s important to consider these factors when interpreting the results. The study also doesn’t specify the duration of activity decline that precedes disability worsening, which is an important area for future research.

What Comes Next: Refining the Approach

The next steps involve larger, more comprehensive studies to validate these findings and explore the clinical utility of activity monitoring in MS. Researchers will need to determine the optimal way to use this technology – for example, how frequently activity should be monitored, and what thresholds should trigger further evaluation. Further investigation is also needed to understand the relationship between activity patterns, brain changes, and other biomarkers of disease progression. The goal is to develop a personalized approach to MS management that incorporates objective activity monitoring to optimize treatment and improve outcomes for people living with this challenging condition.